Jessica Roydhouse

Also affiliated with Menzies School of Health Research, Menzies Institute for Medical Research

Economics, Econometrics and FinanceMedicineMathematicsDecision Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment”.

An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment

Value in Health(2022)10.1016/j.jval.2021.11.1368

N/A

0.870DataRank · unranked

18 citations

Ethan Basch, Carolyn Mead‐Harvey, Antonia V. Bennett, Gina L. Mazza, Gisela Schwab +4 more

Overall side effect assessment of oxaliplatin toxicity in rectal cancer patients in NRG oncology/NSABP R04

Quality of Life Research(2024)10.1007/s11136-024-03746-5

N/A

0.225DataRank · unranked

3 citations

Jessica Roydhouse, Mourad Tighiouart, N. Lynn Henry, Sungjin Kim, Ron D. Hays +4 more

Patient and proxy reports regarding the experience of treatment decision‐making in cancer care

Psycho-Oncology(2020)10.1002/pon.5528

N/A

0DataRank · unranked

6 citations

Roee Gutman, Ira B. Wilson, Kenneth L. Kehl, Nancy L. Keating, Jessica Roydhouse

Recommendations to address respondent burden associated with patient-reported outcome assessment

Nature Medicine(2024)10.1038/s41591-024-02827-9

N/A

0DataRank · unranked

121 citations

Samantha Cruz Rivera, Jessica Roydhouse, Paul Kamudoni, Yvonne Alder, Nicola Anderson +35 more

Overall side‐effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments

Cancer(2025)10.1002/cncr.70084

N/A

0DataRank · unranked

2 citations

Shaili Ganatra, Fengmin Zhao, Ju‐Whei Lee, Jessica Roydhouse, Edward H. Ip +13 more

International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials

Quality of Life Research(2023)10.1007/s11136-023-03396-z

N/A

0DataRank · unranked

13 citations

John Devin Peipert, Thomas M. Atkinson, Cecilia Pompili, Monica Pinto, James W. Shaw +2 more

The estimand framework and its application in substance use disorder clinical trials: a case study

The American Journal of Drug and Alcohol Abuse(2021)10.1080/00952990.2021.1976199

N/A

0DataRank · unranked

2 citations

Lysbeth Floden, Rachel L. Tomko, Kevin M. Gray, Melanie L. Bell, Jessica Roydhouse